PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Composite Nanoparticles
Inquiry

Composite Nanoparticles

Inquiry
Cat. No. Product Name Inquiry
X26-06-ZQ5006 Adenine-functionalized zinc sulfide nanoparticles (Adenine-ZnS)
X26-06-ZQ5008 Gadolinium-doped zinc oxide drug-loaded nanoparticles (ZnO-Gd-DOX)
X26-06-ZQ5012 Thioglycolic acid-modified zinc sulfide nanoparticles (TGA-ZnS / RSH-ZnS)
X26-06-ZQ5015 Disulfide-bridged hybrid hollow mesoporous organosilica nanoparticles (Disulfide-bridged HMONs)
X26-06-ZQ5030 Quantum dots@silica core-shell nanoparticles complexed with PGEA and plasmid DNA (QDs@SiO2-PGEA/pDNA)
X26-06-ZQ5031 Doxorubicin/elacridar co-loaded PLGA/TPGS hybrid nanoparticles (PLGA/TPGS(DOX/Elacridar))
X26-06-ZQ5032 Aggregation-induced emission luminogen-functionalized mesoporous silica nanoparticles (AIE-functionalized MSNs)
X26-06-ZQ5034 Hyaluronic acid-cisplatin/doxorubicin co-loaded drug delivery nanoparticles (HA-CDDP/DOX)
X26-06-ZQ5036 Low molecular weight protamine-modified PLGA nanoparticles (LMWP-PLGA NPs)
X26-06-ZQ5039 Gelatin-siloxane nanoparticles (GSNPs)
X26-06-ZQ5041 Cell membrane-camouflaged tirapazamine-loaded porphyrinic metal-organic framework nanoparticles (TPZ@PCN@Mem)
X26-06-ZQ5043 pH-responsive hyaluronic acid-gossypol nanoparticles (HA-Gossypol NPs)
X26-06-ZQ5048 Silica nanoparticles grafted with poly(N-isopropylacrylamide)-b-poly(4-vinylpyridine) (SNPs-g-PNIPAM-b-P4VP)
X26-06-ZQ5049 Carboxyl-polyethylene glycol-coated magnetite nanoparticles (20 nm PEG-COOH@Fe3O4)
X26-06-ZQ5051 Polyethylene glycol-coated magnetite nanoparticles (140-150 nm PEG@Fe3O4)
X26-06-ZQ5052 Copper sulfide nanodots and doxorubicin co-loaded mesoporous silica nanoparticles (CuSNDs@DOX-MSNs)
X26-06-ZQ5054 Thiol-functionalized hollow mesoporous silica nanoparticles (HMSN-SH)
X26-06-ZQ5058 Gold-coated iron oxide core-shell nanoparticles (Fe2O3@Au NPs)
X26-06-ZQ5059 Gold nanoparticles (15 nm Au NPs)
X26-06-ZQ5060 Amine-polyethylene glycol-coated magnetite nanoparticles (40 nm PEG-NH2@Fe3O4)
X26-06-ZQ5062 Amine-polyethylene glycol-modified gold-coated magnetic nanoparticles (100 nm PEG-NH2@Fe3O4@Au)
X26-06-ZQ5063 Integrin αvβ3-targeted carboxymethyl chitosan-coated magnetite magnetic nanoparticles
X26-06-ZQ5065 Hyaluronidase-functionalized doxorubicin-loaded silica nanoparticles (SiO2(DOX)@HAase)
X26-06-ZQ5066 Biotin and lactobionic acid dual-modified quercetin-loaded nanoparticles
X26-06-ZQ5067 Metalloporphyrin-encapsulated mesoporous silica nanoparticles (Metalloporphyrin/mSiO2)
X26-06-ZQ5069 Bovine serum albumin-modified metalloporphyrin complex nanoparticles (BSA@Metalloporphyrin)
X26-06-ZQ5071 Polyamide polymer-stabilized palladium nanoparticles (Polyamide/Pd NPs)
X26-06-ZQ5073 Nitrogen-doped fluorescent carbon nanoparticles (N-CNPs)
X26-06-ZQ5074 4-Mercaptobenzoic acid-functionalized silica@gold core-shell nanoparticles (SiO2@Au@4-MBA)
X26-06-ZQ5078 Manganese monoxide@silica core-shell targeted nanoparticles (MnO@SiO2)
X26-06-ZQ5079 Cuprous oxide-coated gold core-shell nanoparticles (Au@Cu2O)
X26-06-ZQ5081 c(RGDfC) peptide-functionalized PEG-PCL nanoparticles co-loaded with doxorubicin and chlorin e6
X26-06-ZQ5082 Pullulan-modified calcium carbonate hybrid nanoparticles (Pullulan-CaCO3)
X26-06-ZQ5083 Polydisulfide and triphenylphosphonium dual-modified nanoparticles (CPD/TPP nanoparticles)
X26-06-ZQ5086 Polycaprolactone-coated magnesium silicide nanoparticles (PCL-Mg2Si)
X26-06-ZQ5099 Carboxyl-terminated FITC-labeled PLGA nanoparticles (FITC-PLGA-COOH, 100 nm)
X26-06-ZQ5102 Paclitaxel-loaded PLGA-PEG nanoparticles (PLGA-PEG(PTX))
X26-06-ZQ5107 Aptamer-functionalized ultrasound nanobubbles co-loaded with resveratrol and ultra-small copper-based nanoparticles
X26-06-ZQ5117 Cu5.4O nanoparticles / Ultrasound nanobubbles / Resveratrol-loaded nanobubbles / Ultra-small copper-based nanoparticles
X26-06-ZQ5173 Superparamagnetic iron oxide nanoparticles (SIONs / SPIONs)
PRODUCTS
Featured Products
Nucleic Acid Drug Delivery Products
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010) GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011) GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012) GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014) Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015) Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016) Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017) GalNAc-L96-OH (Cat#: X24-11-YM018) GalNAc-L96-TEA (Cat#: X24-11-YM019)
Hots Products
N-Glycan
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036) A2G2 N-Glycan (Cat#: X23-03-YW037) A2G2S2 N-Glycan (Cat#: X23-03-YW038) A2 N-Glycan (Cat#: X23-03-YW039) A2[6]G1 N-Glycan (Cat#: X23-03-YW040) M3 N-Glycan (Cat#: X23-03-YW041) A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
O-Glycan
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178) Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179) Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180) Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181) Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182) T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192) T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193) Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood Group and Lewis Antigen
Blood group A trisaccharide (Cat#: XCO0060Q) Blood group B trisaccharide (Cat#: XCO0068Q) Blood group H disaccharide (Cat#: XCO0074Q) Lewis A trisaccharide (Cat#: XCO0079Q) 3'-Sulfated lewis A (Cat#: XCO0080Q) Lewis B tetrasaccharide (Cat#: XCO0083Q) Lewis X trisaccharide (Cat#: XCO0085Q) Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Human Milk Oligosaccharides (HMOs)
Lacto-N-biose (Cat#: XCO0089Q) 2'-Fucosyllactose (Cat#: XCO0091Q) 3-Fucosyllactose (Cat#: XCO0092Q) Lactodifucotetraose (Cat#: XCO0093Q) Lacto-N-triose I (Cat#: XCO0094Q) 3'-Sialyllactose sodium salt (Cat#: XCO0096Q) 6'-Sialyllactose sodium salt (Cat#: XCO0098Q) 3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Glycosaminoglycans
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478) FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480) TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481) Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482) Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598) Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611) Heparin disaccharide I-A (Cat#: X22-11-ZQ662) Chondroitine sulfate (Cat#: X23-04-XQ1118)
Carbohydrate Conjugates
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008) Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037) Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038) Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039) Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
Glycolipids
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101) GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112) LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118) Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131) Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146) Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162) Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175) nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Cyclodextrin
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119) Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003) Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004) Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005) Succinyl-γ-cyclodextrin (Cat#: X23-11-B006) ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007) β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008) γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Dextran
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273) Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279) FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280) FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283) TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287) FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291) Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377) TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383) Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.